Log in to save to my catalogue

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion dise...

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion dise...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2186311642

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review

About this item

Full title

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review

Publisher

United States: Public Library of Science

Journal title

PloS one, 2019-02, Vol.14 (2), p.e0212198

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (cas) is a new technology that allows easier manipulation of the genome. Its potential to edit genes opened a new door in treatment development for incurable neurological monogenic diseases (NMGDs). The aim of this systematic review was t...

Alternative Titles

Full title

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2186311642

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2186311642

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0212198

How to access this item